Balance in asthma between matrix metalloproteinases and their inhibitors

Journal of Allergy and Clinical Immunology

Volumn 104, Issue 3 II, 1999, Pages 530-533

  Mautino, Gisèle ^a   Capony, Françoise ^a   Bousquet, Jean ^a   Vignola, Antonio M ^b  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; BECLOMETASONE DIPROPIONATE; COLLAGEN; COLLAGENASE; CORTICOSTEROID; ELASTIN; ENTACTIN; FIBRONECTIN; GELATINASE; GELATINASE B; GLYCOSAMINOGLYCAN; HYALURONIC ACID; LAMININ; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; PROTEOGLYCAN; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

AIRWAY OBSTRUCTION; ASTHMA; EDITORIAL; EXTRACELLULAR MATRIX; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; INHALATIONAL DRUG ADMINISTRATION; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ASTHMA; BASEMENT MEMBRANE; EXTRACELLULAR MATRIX; HUMANS; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; PROTEASE INHIBITORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 0032859197     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(99)70319-2     Document Type: Article

References (23)

1. Raghow R. The role of extracellular matrix in post inflammatory wound healing and fibrosis. Faseb J 1994;8:823-31.
2. Murphy G, Docherty AJ. The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol 1992;7:120-5.
3. Shapiro SD, Senior RM. Matrix metalloproteinases: matrix degradation and more. Am J Respir Cell Mol Biol 1999;20:1100-2.
4. Reed CE. The natural history of asthma in adults: the problem of irreversibility. J Allergy Clin Immunol 1999;103:539-47.
5. Roche WR, Beasley R, Williams JH, Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989;1:520-4.
6. Altraja A, Laitinen A, Virtanen I, et al. Expression of laminins in the airways in vahous types of asthmatic patients: a morphometric study. Am J Respir Cell Mol Biol 1996;15:482-8.
7. Jeffery PK, Wardlaw AJ, Nelson EC, Collins JV, Kay AB. Bronchial biopsies in asthma: an ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989;140:1745-53.
8. Chetta A, Foresi A, Del-Donno M, et al. Bronchial responsiveness to distilled water and methacholine and its relationship to inflammation and remodeling of the airways in asthma. Am J Respir Crit Care Med 1996;153:910-7.
9. Hoshino M, Nakamura Y, Sim J, Shimojo J, Isogai S. Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. J Allergy Clin Immunol 1998;102:783-8.
10. Jeffery PK, Godfrey RW, Adelroth E, Nelson F, Rogers A, Johansson SA. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma: a quantitative light and electron microscopic study. Am Rev Respir Dis 1992;145:890-9.
11. Lundgren R, Soderberg M, Horstedt P, Stenling R. Morphological studies of bronchial mucosal biopsies from asthmatics before and after ten years of treatment with inhaled steroids. Eur Respir J 1988;1:883-9.
12. Trigg CJ, Manolitsas ND, Wang J, et al. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am J Respir Crit Care Med 1994;150:17-22.
13. Olivieri D, Chetta A, Del-Donno M, et al. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. Am J Respir Crit Care Med 1997;155:1864-71.
14. Hoshino M, Nakamura Y, Sim JJ, et al. Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin-like growth factor (IGF)-I expression in bronchial asthma. Clin Exp Allergy 1998;28:568-77.
15. Mautino G, Henriquet C, Jaffuel D, Bousquet J, Capony F. Tissue inhibitor of metalloproteinase-1 levels in BAL fluid from asthmatics. Am J Respir Crit Care Med 1999;60:324-30.
16. Vignola A, Riccobono L, Mirabella A, et al. Sputum TIMP-I to MMP-9 ratio correlates with airflow obstruction in asthma and COPD. Am J Respir Grit Care Med 1998;158:1945-50.
17. Lemjabbar H, Gosset P, Lamblin C, et al. Contribution of 92 kDa gelatinase/type IV collagenase in bronchial inflammation during status asthmaticus. Am J Respir Grit Care Med 1999;159:1298-307.
18. Mautino G, Henriquet C, Gougat C, et al. Increased expression of tissue inhibitor of metalloproteinase-1 and loss of correlation with matrix metalloproteinase-9 by macrophages in asthma. Lab Invest 1999;79:39-47.
19. Mautino G, Oliver N, Chanez P, Bousquet J, Capony F. Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. Am J Respir Cell Mol Biol 1997;17:583-91.
20. Ohno I, Ohtani H, Nitta Y, et al. Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. Am J Respir Cell Mol Biol 1997;16:212-9.
21. Shapiro SD, Campbell EJ, Kobayashi DK, Welgus HG. Dexamethasone selectively modulates basal and lipopolysaccharide-induced metalloproteinase and tissue inhibitor of metalloproteinase production by human alveolar macrophages. J Immunol 1991;146:2724-9.
22. Clark SD, Kobayashi DK, Welgus HG. Regulation of the expression of tissue inhibitor of metalloproteinases and collagenase by retinoids and glucocorticoids in human fibroblasts. J Clin Invest 1987;80:1280-8.
23. Bosse M, Chakir J, Rouabhia M, Boulet LP, Audette M, Laviolette M. Serum matrix metalloproteinase-9:tissue inhibitor of metalloproteinase-1 ratio correlates with steroid responsiveness in moderate to severe asthma. Am J Respir Crit Care Med 1999;159:596-602.